These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8814521)

  • 1. AIDS-related obsessive compulsive disorder: deconditioning based on fluoxetine-induced inhibition of anxiety.
    Kraus RP; Nicholson IR
    J Behav Ther Exp Psychiatry; 1996 Mar; 27(1):51-6. PubMed ID: 8814521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive disorder. Diagnosis and management.
    Ladouceur R; Freeston M; Gagnon F
    Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of obsessive compulsive disorder in the elderly: a review and case example.
    Calamari JE; Faber SD; Hitsman BL; Poppe CJ
    J Behav Ther Exp Psychiatry; 1994 Jun; 25(2):95-104. PubMed ID: 7983229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive-behavioral therapy for children who have obsessive-compulsive disorder.
    Piacentini J; Langley AK
    J Clin Psychol; 2004 Nov; 60(11):1181-94. PubMed ID: 15389618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP; Sobhan MA
    Pak J Pharm Sci; 2013 Jan; 26(1):95-8. PubMed ID: 23261733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
    Simpson HB; Gorfinkle KS; Liebowitz MR
    J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder.
    Zitterl W; Meszaros K; Hornik K; Twaroch T; Dossenbach M; Zitterl-Eglseer K; Zapotoczky HG
    Wien Klin Wochenschr; 1999 Jun; 111(11):439-42. PubMed ID: 10420495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of compulsive hoarding.
    Saxena S; Maidment KM
    J Clin Psychol; 2004 Nov; 60(11):1143-54. PubMed ID: 15389621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure with response prevention and serotonergic antidepressants in the treatment of obsessive compulsive disorder: a review and implications for interdisciplinary treatment.
    Abel JL
    Behav Res Ther; 1993 Jun; 31(5):463-78. PubMed ID: 8101439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
    Prazeres AM; Souza WF; Fontenelle LF
    Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding and treating incompleteness in obsessive-compulsive disorder.
    Summerfeldt LJ
    J Clin Psychol; 2004 Nov; 60(11):1155-68. PubMed ID: 15389620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden remission of obsessive-compulsive disorder by involuntary, massive exposure.
    Fontenelle L; Soares ID; Marques C; Rangé B; Mendlowicz MV; Versiani M
    Can J Psychiatry; 2000 Sep; 45(7):666-7. PubMed ID: 11056831
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
    Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adolescent male with features of EDNOS and obsessive-compulsive disorder.
    Yanover T; Thompson JK; Straub DM
    Eat Weight Disord; 2008 Jun; 13(2):e20-4. PubMed ID: 18612248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-patient treatment for resistant obsessive-compulsive disorder.
    Al-Sughayir MA
    Saudi Med J; 2000 Feb; 21(2):193-5. PubMed ID: 11533781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming treatment resistance in obsessive-compulsive disorder.
    O'Connor K
    Acta Psychiatr Scand; 2005 Apr; 111(4):257-60. PubMed ID: 15740461
    [No Abstract]   [Full Text] [Related]  

  • 18. Case study: successful medication withdrawal using cognitive-behavioral therapy for a preadolescent with OCD.
    Sallinen BJ; Nangle DW; O'Grady AC
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1441-4. PubMed ID: 15502604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine.
    Kampman M; Keijsers GP; Hoogduin CA; Verbraak MJ
    Acta Psychiatr Scand; 2002 Oct; 106(4):314-9. PubMed ID: 12225499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder.
    Hoexter MQ; Dougherty DD; Shavitt RG; D'Alcante CC; Duran FL; Lopes AC; Diniz JB; Batistuzzo MC; Evans KC; Bressan RA; Busatto GF; Miguel EC
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):569-80. PubMed ID: 22841131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.